Genetic Testing in the Myelodysplastic Syndromes: Molecular Insights Into Hematologic Diversity

This publication has 100 references indexed in Scilit:

• Systematic screening at diagnosis of −5/del(5)(q31), −7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics
  Cancer Genetics and Cytogenetics, 2004
• Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six Genes
  New England Journal of Medicine, 2004
• Low frequency of FLT3 gene internal tandem duplication and activating loop mutation in therapy-related acute myelocyticleukemia and myelodysplastic syndrome
  Cancer Genetics and Cytogenetics, 2004
• A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
  New England Journal of Medicine, 2002
• Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome
  American Journal of Hematology, 2002
• Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes
  Oncogene, 2000
• Hypermethylation of tumor suppressor genes in cancer
  Seminars in Cancer Biology, 1999
• Novel Genes Mapping to the Critical Region of the 5q− Syndrome
  Genomics, 1997
• 5q-, twenty-five years later: a Synopsis
  Cancer Genetics and Cytogenetics, 1997
• Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome
  Cancer Genetics and Cytogenetics, 1995